top of page

Aries Biotech Partners with NeuroTheranostics, Inc.

Peptide-based Strategies for Healing Neurological Damage

Aries Biotech and NeuroTheranostics are merging their collective expertise in research and development to address potential impact of synthetic, protease-targeting compounds upon the central nervous system. These strategies have the potential to mitigate a broad spectrum of injuries and diseases.

To learn how we can assist with your needs within science and medicine, visit Aries Biotech at

22 views0 comments

Recent Posts

See All

Honored to serve as a guest speaker for the Neuroscience Roadmap Scholars Program within the Department of Neurobiology, University of Alabama at Birmingham. A link to the UAB Neuroscience Program ma

Aries Biotech is pleased to announce new hours of operation! Effective 01 October 2022, hours of operation will be Monday-Thursday, 8am to 6pm (PST) by appointment. This change will help to accommod

bottom of page